Moreover, our results revealed that SMYD3 could upregulate the expression of target genes and the invasion and metastasis ability of breast cancer cells, while TGF‐β inhibitor SB431542 could significantly inhibit these promoting effects of SMYD3 (Figure S8D, E, Supporting Information). The gene discussed is SMYD3; the disease is breast carcinoma.